Literature DB >> 27923948

Decreased Rate of Plasma Arginine Appearance in Murine Malaria May Explain Hypoargininemia in Children With Cerebral Malaria.

Matthew S Alkaitis1,2, Honghui Wang3, Allison K Ikeda1, Carol A Rowley1, Ian J C MacCormick4,5,6, Jessica H Chertow1, Oliver Billker7, Anthony F Suffredini3, David J Roberts2,8, Terrie E Taylor9,10, Karl B Seydel9,10, Hans C Ackerman1.   

Abstract

BACKGROUND: Plasmodium infection depletes arginine, the substrate for nitric oxide synthesis, and impairs endothelium-dependent vasodilation. Increased conversion of arginine to ornithine by parasites or host arginase is a proposed mechanism of arginine depletion.
METHODS: We used high-performance liquid chromatography to measure plasma arginine, ornithine, and citrulline levels in Malawian children with cerebral malaria and in mice infected with Plasmodium berghei ANKA with or without the arginase gene. Heavy isotope-labeled tracers measured by quadrupole time-of-flight liquid chromatography-mass spectrometry were used to quantify the in vivo rate of appearance and interconversion of plasma arginine, ornithine, and citrulline in infected mice.
RESULTS: Children with cerebral malaria and P. berghei-infected mice demonstrated depletion of plasma arginine, ornithine, and citrulline. Knock out of Plasmodium arginase did not alter arginine depletion in infected mice. Metabolic tracer analysis demonstrated that plasma arginase flux was unchanged by P. berghei infection. Instead, infected mice exhibited decreased rates of plasma arginine, ornithine, and citrulline appearance and decreased conversion of plasma citrulline to arginine. Notably, plasma arginine use by nitric oxide synthase was decreased in infected mice.
CONCLUSIONS: Simultaneous arginine and ornithine depletion in malaria parasite-infected children cannot be fully explained by plasma arginase activity. Our mouse model studies suggest that plasma arginine depletion is driven primarily by a decreased rate of appearance. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  endothelium; host response; metabolism; nitric oxide; plasmodium; urea cycle

Mesh:

Substances:

Year:  2016        PMID: 27923948      PMCID: PMC5142086          DOI: 10.1093/infdis/jiw452

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase.

Authors:  B R Flam; P J Hartmann; M Harrell-Booth; L P Solomonson; D C Eichler
Journal:  Nitric Oxide       Date:  2001-04       Impact factor: 4.427

2.  Human type II arginase: sequence analysis and tissue-specific expression.

Authors:  S M Morris; D Bhamidipati; D Kepka-Lenhart
Journal:  Gene       Date:  1997-07-09       Impact factor: 3.688

3.  Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria.

Authors:  Irene Gramaglia; Peter Sobolewski; Diana Meays; Ramiro Contreras; John P Nolan; John A Frangos; Marcos Intaglietta; Henri C van der Heyde
Journal:  Nat Med       Date:  2006-11-12       Impact factor: 53.440

4.  Analysis of 25 underivatized amino acids in human plasma using ion-pairing reversed-phase liquid chromatography/time-of-flight mass spectrometry.

Authors:  Michael Armstrong; Karen Jonscher; Nichole A Reisdorph
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

5.  The distribution and intensity of parasite sequestration in comatose Malawian children.

Authors:  Karl B Seydel; Danny A Milner; Steve B Kamiza; Malcolm E Molyneux; Terrie E Taylor
Journal:  J Infect Dis       Date:  2006-06-13       Impact factor: 5.226

6.  Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow.

Authors:  Supattra Serirom; Wahaju H Raharjo; Kesinee Chotivanich; Sornchai Loareesuwan; Paul Kubes; May Ho
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

7.  ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria.

Authors:  Quirijn de Mast; Evelyn Groot; Puji B Asih; Din Syafruddin; Marije Oosting; Silvie Sebastian; Bart Ferwerda; Mihai G Netea; Philip G de Groot; Andre J A M van der Ven; Rob Fijnheer
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

8.  Quantitative study in vivo of methionine cycle in humans using [methyl-2H3]- and [1-13C]methionine.

Authors:  K J Storch; D A Wagner; J F Burke; V R Young
Journal:  Am J Physiol       Date:  1988-09

9.  The neuropathology of fatal cerebral malaria in malawian children.

Authors:  Katerina Dorovini-Zis; Kristopher Schmidt; Hanh Huynh; Wenjiang Fu; Richard O Whitten; Dan Milner; Steve Kamiza; Malcolm Molyneux; Terrie E Taylor
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

10.  Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria.

Authors:  Lena Serghides; Hani Kim; Ziyue Lu; Dylan C Kain; Chris Miller; Roland C Francis; W Conrad Liles; Warren M Zapol; Kevin C Kain
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

View more
  13 in total

1.  Kinetic and Cross-Sectional Studies on the Genesis of Hypoargininemia in Severe Pediatric Plasmodium falciparum Malaria.

Authors:  Matthew P Rubach; Haoyue Zhang; Salvatore M Florence; Jackson P Mukemba; Ayam R Kalingonji; Nicholas M Anstey; Tsin W Yeo; Bert K Lopansri; J Will Thompson; Esther D Mwaikambo; Sarah Young; David S Millington; J Brice Weinberg; Donald L Granger
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

2.  Distinct amino acid and lipid perturbations characterize acute versus chronic malaria.

Authors:  Regina Joice Cordy; Rapatbhorn Patrapuvich; Loukia N Lili; Monica Cabrera-Mora; Jung-Ting Chien; Gregory K Tharp; Manoj Khadka; Esmeralda Vs Meyer; Stacey A Lapp; Chester J Joyner; AnaPatricia Garcia; Sophia Banton; ViLinh Tran; Viravarn Luvira; Siriwan Rungin; Teerawat Saeseu; Nattawan Rachaphaew; Suman B Pakala; Jeremy D DeBarry; Jessica C Kissinger; Eric A Ortlund; Steven E Bosinger; John W Barnwell; Dean P Jones; Karan Uppal; Shuzhao Li; Jetsumon Sattabongkot; Alberto Moreno; Mary R Galinski
Journal:  JCI Insight       Date:  2019-05-02

Review 3.  Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.

Authors:  Andrea M Weckman; Chloe R McDonald; Jo-Anna B Baxter; Wafaie W Fawzi; Andrea L Conroy; Kevin C Kain
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

4.  Interplay between Plasmodium falciparum haemozoin and L-arginine: implication for nitric oxide production.

Authors:  Yolanda Corbett; Sarah D'Alessandro; Silvia Parapini; Diletta Scaccabarozzi; Parisa Kalantari; Stefania Zava; Flavio Giavarini; Donatella Caruso; Irma Colombo; Timothy J Egan; Nicoletta Basilico
Journal:  Malar J       Date:  2018-12-06       Impact factor: 2.979

5.  Malaria in pregnancy alters l-arginine bioavailability and placental vascular development.

Authors:  Chloe R McDonald; Lindsay S Cahill; Joel L Gamble; Robyn Elphinstone; Lisa M Gazdzinski; Kathleen J Y Zhong; Adrienne C Philson; Mwayiwawo Madanitsa; Linda Kalilani-Phiri; Victor Mwapasa; Feiko O Ter Kuile; John G Sled; Andrea L Conroy; Kevin C Kain
Journal:  Sci Transl Med       Date:  2018-03-07       Impact factor: 17.956

6.  Amino acid derangements in adults with severe falciparum malaria.

Authors:  Stije J Leopold; Siribha Apinan; Aniruddha Ghose; Hugh W Kingston; Katherine A Plewes; Amir Hossain; Asok Kumar Dutta; Sujat Paul; Anupam Barua; Abdus Sattar; Nicholas P J Day; Joel Tarning; Markus Winterberg; Nicholas J White; Arjen M Dondorp
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

7.  Citrulline protects mice from experimental cerebral malaria by ameliorating hypoargininemia, urea cycle changes and vascular leak.

Authors:  Irene Gramaglia; Joyce Velez; Yu-Sun Chang; Wilson Caparros-Wanderley; Valery Combes; Georges Grau; Monique F Stins; Henri C van der Heyde
Journal:  PLoS One       Date:  2019-03-08       Impact factor: 3.240

8.  Insights into malaria pathogenesis gained from host metabolomics.

Authors:  Heather N Colvin; Regina Joice Cordy
Journal:  PLoS Pathog       Date:  2020-11-12       Impact factor: 6.823

9.  Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine.

Authors:  Peng Kai Ong; Aline S Moreira; Cláudio T Daniel-Ribeiro; John A Frangos; Leonardo J M Carvalho
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

10.  L-arginine supplementation and thromboxane synthase inhibition increases cerebral blood flow in experimental cerebral malaria.

Authors:  Aline S Moreira; Vanessa Estato; David C Malvar; Guilherme S Sanches; Fabiana Gomes; Eduardo Tibirica; Cláudio Tadeu Daniel-Ribeiro; Leonardo J M Carvalho
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.